Erschienen in:
15.07.2019 | Letter to the Editor
Letter to the Editor concerning “Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study” by Fischgrund JS, et al. [Eur Spine J; (2018) 27(5): 1146–1156]
verfasst von:
Yongchao Li, Xiaofei Feng, Jun Tan, Baogan Peng
Erschienen in:
European Spine Journal
|
Ausgabe 9/2019
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the study by Fischgrund JS et al., which appeared in the European Spine Journal. In this prospective randomized double-blind sham-controlled multicenter study, they demonstrated the efficacy of intraosseous radiofrequency ablation of the basivertebral nerve to treat chronic low back pain in patients with Modic type 1 or 2 changes of the vertebral endplates. At the same time, treatment was limited to a minimum of two and a maximum of three consecutive vertebral body levels from L3–S1. Most commonly, L5–S1 (122/224 patients) and L4–L5 (45/224) followed by L4–L5–S1 (41/224) were treated. In other words, a total of 163 S1 vertebral bodies (72.77%) were treated. Targeted location was the branch point or terminus of the basivertebral nerve, typically between 40 and 60% of the posterior to anterior distance across the vertebral body. …